|
CIED procedure - no. (%)
|
|
New implant
|
|
Pacemaker
|
|
Single or dual chamber
|
131
|
31.9%
|
81
|
31.5%
|
50
|
32.5%
|
|
Cardiac resynchronization therapy
|
14
|
3.4%
|
9
|
3.5%
|
5
|
3.3%
|
|
Implantable cardioverter-defibrillator
|
|
Single or dual chamber
|
21
|
5.1%
|
6
|
2.3%
|
15
|
9.7%
|
|
Cardiac resynchronization therapy
|
27
|
6.6%
|
9
|
3.5%
|
18
|
11.7%
|
|
Device replacement or revision
|
|
Pulse-generator change only
|
191
|
46.5%
|
129
|
50.2%
|
6
|
40.3%
|
|
Pulse-generator change with additional procedure
|
27
|
6.6%
|
23
|
9.0%
|
4
|
2.6%
|
|
INR on day of surgery - mean ± S.D.
|
1.44
|
± 0.22
|
1.44
|
± 0.21
|
1.43
|
± 0.24
|
|
Warfarin resumption after surgery -days
|
|
Mean ± S.D.
|
0.46
|
± 1.01
|
0.23
|
± 0.51
|
0.84
|
± 1.45
|
|
Median, IQR
|
0
|
0–1
|
0
|
0–0
|
0
|
0–1
|
|
Anti-coagulation interruption period - days
|
|
Mean ± S.D.
|
4.04
|
± 2.04
|
3.91
|
± 1.71
|
4.27
|
± 2.47
|
|
Median (IQR)
|
3
|
3–5
|
3
|
3–5
|
4
|
3–5
|
